Plant Advanced Technologies Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Plant Advanced Technologies's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs Industry Growth | 30.8% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Revenue & Expenses Breakdown
How Plant Advanced Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 2 | -1 | 4 | 0 |
| 30 Sep 22 | 1 | -1 | 4 | 0 |
| 30 Jun 22 | 5 | -1 | 4 | 0 |
| 31 Mar 22 | 4 | -1 | 3 | 0 |
| 31 Dec 21 | 2 | -1 | 3 | 0 |
| 30 Sep 21 | 5 | -1 | 4 | 0 |
| 30 Jun 21 | 3 | -1 | 2 | 0 |
| 31 Mar 21 | 2 | -1 | 2 | 0 |
| 31 Dec 20 | 3 | -1 | 3 | 0 |
| 30 Sep 20 | 2 | -1 | 2 | 0 |
| 30 Jun 20 | 2 | -1 | 2 | 0 |
| 31 Mar 20 | 2 | -1 | 2 | 0 |
| 31 Dec 19 | 2 | -1 | 2 | 0 |
| 30 Sep 19 | 2 | 0 | 1 | 0 |
| 30 Jun 19 | 2 | 1 | 2 | 0 |
| 31 Mar 19 | 2 | 1 | 2 | 0 |
| 31 Dec 18 | 2 | 1 | 2 | 0 |
| 30 Sep 18 | 2 | 0 | 2 | 0 |
| 30 Jun 18 | 2 | -1 | 2 | 0 |
| 31 Mar 18 | 2 | -1 | 2 | 0 |
| 31 Dec 17 | 1 | -1 | 2 | 0 |
| 30 Sep 17 | 2 | -1 | 2 | 0 |
| 30 Jun 17 | 2 | 0 | 2 | 0 |
| 31 Mar 17 | 2 | -1 | 2 | 0 |
| 31 Dec 16 | 2 | -1 | 2 | 0 |
| 30 Sep 16 | 2 | -1 | 2 | 0 |
| 30 Jun 16 | 2 | -2 | 2 | 0 |
| 31 Mar 16 | 2 | -1 | 2 | 0 |
| 31 Dec 15 | 2 | -1 | 1 | 0 |
| 30 Sep 15 | 2 | -1 | 1 | 0 |
| 30 Jun 15 | 2 | -1 | 1 | 0 |
| 31 Mar 15 | 2 | -1 | 1 | 0 |
| 31 Dec 14 | 2 | -1 | 1 | 0 |
| 30 Sep 14 | 2 | 0 | 1 | 0 |
| 30 Jun 14 | 2 | 0 | 1 | 0 |
| 31 Mar 14 | 2 | 0 | 1 | 0 |
| 31 Dec 13 | 2 | 0 | 1 | 0 |
Quality Earnings: Insufficient data to determine if ALPAT has high quality earnings.
Growing Profit Margin: Insufficient data to determine if ALPAT's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ALPAT's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare ALPAT's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if ALPAT's earnings growth over the past year exceeded the Biotechs industry average.
Return on Equity
High ROE: ALPAT has a negative Return on Equity (0%), as it is currently unprofitable.